pharmaphorum

JANUARY 18, 2022

Almirall and IRB Barcelona (the Institute for Research in Biomedicine), will conduct research using molecular glue degraders, a new approach to the skin diseases under scrutiny. The post Almirall and IRB Barcelona team up to tackle skin disease appeared first on.

Dermatology 52

Dermatology Protein Pharma Companies Research 52

Drug Discovery World

NOVEMBER 9, 2023

Overcoming expression and production challenges for unique proteins This session will begin with chairperson’s remarks from Mercedes Márquez Martínez, PhD, Technical Coordinator & Acting Scientific Director, Protein Production Platform (PPP) – Nanbiosis, Autonomous, University of Barcelona (UAB).

Engineer 52

Engineer Antibody Protein In-Vivo 52

Drug Discovery World

NOVEMBER 13, 2023

Fabian Mohr, PhD, Vice President Research & Development, IBA Lifesciences, on: ‘Developing a robust affinity tag platform using engineered streptavidin’. Opher Gileadi, PhD, Head, Protein Science SGC, Karolinska Institute, on: ‘Targeting every human protein: Challenges and prospects’.

Protein 59

Protein Antibody Engineer Scientist 59